These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 793553)
1. Immunotherapy in the management of myelogenous leukemia. Fairley GH Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553 [TBL] [Abstract][Full Text] [Related]
2. The role of immunotherapy in acute myelogenous leukemia. Foon KA; Smalley RV; Riggs CW; Gale RP Arch Intern Med; 1983 Sep; 143(9):1726-31. PubMed ID: 6577818 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in acute leukemias. Possible applications in children. Mahoney DH; Starling KA Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of acute myelogenous leukemia in man. Powles R Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324 [No Abstract] [Full Text] [Related]
5. Immunotherapy of leukemia and lymphoma. Murphy S; Hersh E Semin Hematol; 1978 Apr; 15(2):181-203. PubMed ID: 418506 [No Abstract] [Full Text] [Related]
6. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse. Powles R; Toy JL Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466 [TBL] [Abstract][Full Text] [Related]
7. Clinical immunotherapy experiences in the Southeastern Cancer Study Group. Gordon DS Dev Biol Stand; 1977 Apr 13-15; 38():567-72. PubMed ID: 344110 [TBL] [Abstract][Full Text] [Related]
8. Active specific immunotherapy for acute myelogenous leukaemia. Powles R Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353 [No Abstract] [Full Text] [Related]
9. [Immunology and immunotherapy of leukemia (basic results of 8-years research)]. Bergol'ts VM Vopr Onkol; 1978; 24(11):16-24. PubMed ID: 283626 [TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy of acute myelogenous leukemia (AML) in adults with the Nocardia rubra cell wall skeleton]. Ohno R; Nakamura H; Kodera Y; Masaoka T; Yamada K Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1264-9. PubMed ID: 3524463 [TBL] [Abstract][Full Text] [Related]
11. Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia. Alsabti EA; Taleb AM; Raji HM; Kalil OZ; Saleh KA Jpn J Exp Med; 1979 Jun; 49(3):157-68. PubMed ID: 385948 [TBL] [Abstract][Full Text] [Related]
12. Chemo-immunotherapy versus chemotherapy in acute myeloid leukemia. Preliminary results. Fiere D; Doillon M; Martin C; Vu Van T; Revol L Biomedicine; 1976 Dec; 25(9):318. PubMed ID: 1069595 [TBL] [Abstract][Full Text] [Related]
13. Specificity of heteroantisera to human acute leukemia-associated antigens. Baker MA; Ramachandar K; Taub RN J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196 [TBL] [Abstract][Full Text] [Related]
14. [Results of immunotherapy of acute leukemias with BCG vaccine of Polish production]. Kardaszewicz E; Japa J Acta Haematol Pol; 1975; 6(2):149-55. PubMed ID: 1057344 [TBL] [Abstract][Full Text] [Related]
15. BCG in the therapy of cancer. Delmonte L; Oettgen HF Clin Bull; 1975; 5(2):69-71. PubMed ID: 776445 [No Abstract] [Full Text] [Related]
16. [BCG and irradiated allogenic blast cells in maintenance chemotherapy of children with acute lymphoblastic leukemia in remission. A controlled study]. Ortega JJ; Javier G Sangre (Barc); 1982; 27(3):349-57. PubMed ID: 6760428 [No Abstract] [Full Text] [Related]